Autor:	A Maniati, Epaminondas Zakynthinos, Christina Routsi, A Maggina, Dimitrios Matamis, George Nakos, G Thomopoulos, Nektaria Xirouchaki, M Peftoulidou, K Mandragos, A Michalopoulos, G Vasiliadou, Dimitris Georgopoulos, George Dimopoulos
Rok vydání:	2005
Předmět:	medicine.medical_specialty business.industry Critically ill Critical Care and Intensive Care Medicine law.invention law Erythropoietin Emergency medicine Erythropoietin therapy Recombinant DNA medicine Maximum duration Intensive care medicine business medicine.drug
Zdroj:	Critical Care. 9:P336
ISSN:	1364-8535
DOI:	10.1186/cc3399
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c2fc3bb15ccc6791c035c4b131bbff7b https://doi.org/10.1186/cc3399 Zobrazit plný text záznamu Full text from SpringerLink